Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2023 Filed Jun 22, 2023 22:32 UTC Amendment |
Wettig ThaneChief Commercial Officer
|
SaleCommon Stock | 1,286 | $17.04 | $21,910.48 |
DisclosureSEC source: 0001209191-23-039157 · doc4a.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,052 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| June 07, 2023 Filed Jun 22, 2023 22:32 UTC Amendment |
Wettig ThaneChief Commercial Officer
|
SaleCommon Stock | 472 | $17.04 | $8,040.80 |
DisclosureSEC source: 0001209191-23-039157 · doc4a.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,338 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. F2 · balance_after: Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:22 UTC |
Eisner MarkEVP, Chief Medical Officer
|
SaleCommon Stock | 1,090 | $18.83 | $20,524.70 |
DisclosureSEC source: 0001209191-23-034288 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · EVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,904 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| April 10, 2023 Filed Apr 11, 2023 20:59 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
SaleCommon Stock | 1,869 | $19.52 | $36,482.88 |
DisclosureSEC source: 0001209191-23-024026 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,999 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 20:32 UTC |
Eisner MarkChief Medical Officer
|
SaleCommon Stock | 9,182 | $18.78 | $172,472.85 |
DisclosureSEC source: 0001209191-23-023592 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,994 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 20:28 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 6,590 | $18.78 | $123,785.24 |
DisclosureSEC source: 0001209191-23-023591 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,460 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 23, 2023 Filed Mar 25, 2023 00:27 UTC |
Wettig ThaneChief Commercial Officer
|
SaleCommon Stock | 905 | $18.71 | $16,932.55 |
DisclosureSEC source: 0001209191-23-021138 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,653 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 20, 2023 Filed Mar 29, 2023 21:05 UTC |
Wettig ThaneChief Commercial Officer
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021539 · doc4.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 1,000 F1 · balance_after: The share total in column 5 reflects ownership as of March 28, 2023. Read SEC document |
| March 20, 2023 Filed Mar 29, 2023 21:05 UTC |
Wettig ThaneChief Commercial Officer
|
GiftCommon Stock | 2,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021539 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,310 F1 · balance_after: The share total in column 5 reflects ownership as of March 28, 2023. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:58 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 2,914 | $20.20 | $58,854.93 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,050 F5 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:58 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 4,692 | $20.20 | $94,765.73 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,964 F4 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:55 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
SaleCommon Stock | 19,486 | $20.20 | $393,564.59 |
DisclosureSEC source: 0001209191-23-018064 · doc4.xml · nonDerivative · entry 5 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,868 F4 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:55 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
SaleCommon Stock | 12,103 | $20.20 | $244,447.92 |
DisclosureSEC source: 0001209191-23-018064 · doc4.xml · nonDerivative · entry 4 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,357 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:55 UTC |
Eisner MarkChief Medical Officer
|
SaleCommon Stock | 6,255 | $20.20 | $126,334.11 |
DisclosureSEC source: 0001209191-23-018063 · doc4.xml · nonDerivative · entry 5 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,176 F5 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:55 UTC |
Eisner MarkChief Medical Officer
|
SaleCommon Stock | 3,885 | $20.20 | $78,466.51 |
DisclosureSEC source: 0001209191-23-018063 · doc4.xml · nonDerivative · entry 4 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,431 F4 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:54 UTC |
Graham JuanChief Financial Officer
|
SaleCommon Stock | 2,344 | $20.20 | $47,342.47 |
DisclosureSEC source: 0001209191-23-018062 · doc4.xml · nonDerivative · entry 6 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,868 F5 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:54 UTC |
Graham JuanChief Financial Officer
|
SaleCommon Stock | 1,456 | $20.20 | $29,407.27 |
DisclosureSEC source: 0001209191-23-018062 · doc4.xml · nonDerivative · entry 5 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,212 F4 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:54 UTC |
Graham JuanChief Financial Officer
|
SaleCommon Stock | 1,112 | $20.20 | $22,459.40 |
DisclosureSEC source: 0001209191-23-018062 · doc4.xml · nonDerivative · entry 4 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,668 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:53 UTC |
Wettig ThaneChief Commercial Officer
|
SaleCommon Stock | 4,731 | $20.20 | $95,553.43 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 5 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,558 F4 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:53 UTC |
Wettig ThaneChief Commercial Officer
|
SaleCommon Stock | 2,938 | $20.20 | $59,339.67 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 4 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,289 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 23, 2023 20:50 UTC Amendment |
Conterno Enrique ADirector · Chief Executive Officer
|
SaleCommon Stock | 19,489 | $20.20 | $393,625.18 |
DisclosureSEC source: 0001209191-23-020781 · doc4a.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,868 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:58 UTC |
Chung ChristineSVP, China Operations
|
GrantCommon Stock | 9,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,656 F3 · shares: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:58 UTC |
Chung ChristineSVP, China Operations
|
GrantCommon Stock | 5,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,318 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:58 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 8,354 | $21.16 | $176,736.39 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,519 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:55 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
GrantCommon Stock | 37,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018064 · doc4.xml · nonDerivative · entry 3 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,460 F3 · shares: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:55 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
GrantCommon Stock | 23,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018064 · doc4.xml · nonDerivative · entry 2 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,231 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:55 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
SaleCommon Stock | 24,672 | $21.16 | $521,958.36 |
DisclosureSEC source: 0001209191-23-018064 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,111 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:55 UTC |
Eisner MarkChief Medical Officer
|
GrantCommon Stock | 12,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018063 · doc4.xml · nonDerivative · entry 3 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,316 F3 · shares: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:55 UTC |
Eisner MarkChief Medical Officer
|
GrantCommon Stock | 7,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018063 · doc4.xml · nonDerivative · entry 2 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,865 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:55 UTC |
Eisner MarkChief Medical Officer
|
SaleCommon Stock | 7,363 | $21.16 | $155,770.89 |
DisclosureSEC source: 0001209191-23-018063 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,133 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:54 UTC |
Graham JuanChief Financial Officer
|
GrantCommon Stock | 4,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018062 · doc4.xml · nonDerivative · entry 3 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,780 F3 · shares: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023 Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:54 UTC |
Graham JuanChief Financial Officer
|
GrantCommon Stock | 2,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018062 · doc4.xml · nonDerivative · entry 2 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,112 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:54 UTC |
Graham JuanChief Financial Officer
|
SaleCommon Stock | 2,749 | $21.16 | $58,157.57 |
DisclosureSEC source: 0001209191-23-018062 · doc4.xml · nonDerivative · entry 1 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,213 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:53 UTC |
Wettig ThaneChief Commercial Officer
|
GrantCommon Stock | 9,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 3 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,227 F3 · shares: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:53 UTC |
Wettig ThaneChief Commercial Officer
|
GrantCOmmon Stock | 5,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,889 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:53 UTC |
Wettig ThaneChief Commercial Officer
|
SaleCommon Stock | 6,265 | $21.16 | $132,541.71 |
DisclosureSEC source: 0001209191-23-018061 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,090 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:59 UTC |
Eisner MarkChief Medical Officer
|
SaleCommon Stock | 1,187 | $21.87 | $25,959.69 |
DisclosureSEC source: 0001209191-23-016362 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,496 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:42 UTC |
Wettig ThaneChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001209191-23-012430 · doc4.xml · derivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2033-02-20 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:42 UTC |
Wettig ThaneChief Commercial Officer
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012430 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,355 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:41 UTC |
Graham JuanChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001209191-23-012428 · doc4.xml · derivative · entry 2 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2033-02-20 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:41 UTC |
Graham JuanChief Financial Officer
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012428 · doc4.xml · nonDerivative · entry 1 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,962 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:39 UTC |
Chung ChristineSVP, China Operations
|
GrantStock Option (Right to Buy) · Derivative | 42,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001209191-23-012426 · doc4.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2033-02-20 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:39 UTC |
Chung ChristineSVP, China Operations
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012426 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,873 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:38 UTC |
Eisner MarkChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001209191-23-012425 · doc4.xml · derivative · entry 2 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2033-02-20 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:38 UTC |
Eisner MarkChief Medical Officer
|
GrantCommon Stock | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012425 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,683 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:29 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 143,100 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001209191-23-012423 · doc4.xml · derivative · entry 3 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,100 Underlying: Common Stock · 143,100 shares Expires 2033-02-20 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:29 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
GrantCommon Stock | 85,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012423 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,783 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 21:46 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
SaleCommon Stock | 1,538 | $19.95 | $30,683.10 |
DisclosureSEC source: 0001209191-23-002803 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,483 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. F2 · balance_after: Includes one share acquired on November 15, 2022 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 23:38 UTC |
Wettig ThaneChief Commercial Officer
|
SaleCommon Stock | 734 | $15.80 | $11,597.20 |
DisclosureSEC source: 0001209191-22-062858 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,163 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| December 12, 2022 Filed Dec 15, 2022 02:55 UTC |
Graham JuanChief Financial Officer
|
SaleCommon Stock | 1,407 | $14.50 | $20,401.50 |
DisclosureSEC source: 0001209191-22-061328 · doc4.xml · nonDerivative · entry 2 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,703 F2 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.